Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03792178 |
Date of registration:
|
01/01/2019 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Evaluation of Post-operative Sensitivity of Bulk Fill Resin Composite Versus the Nano Resin Composite.
EPSBN |
Scientific title:
|
Evaluation of Post-operative Sensitivity of Bulk Fill Resin Composite Versus the Nano Resin Composite. |
Date of first enrolment:
|
September 1, 2016 |
Target sample size:
|
60 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03792178 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients must show no signs of spontaneous dental or orofacial pain.
- The presence of molar and premolar class II teeth requiring composite restorations for
the treatment of primary carious lesions
- The selected teeth should have an occlusal contact with natural or crowned antagonist
teeth
- The selected teeth should have a proximal contact with the adjacent teeth.
- Shallow and mid-sized cavity depths will be included in the study .
Exclusion Criteria:
- Increasing pre-operative sensitivity of the selected teeth.
- Teeth with abnormal periapical anatomy or caries that will be likely to result in very
deep restorations.
- Teeth with old restorations or severely destructed dental crowns.
- Teeth with spontaneous pain
- Tempro-mandibular joint problems involving symptomatic pain.
- Patients taking analgesics that could alter their normal pain perception level.
- Pregnancy or breast feeding, acute and chronic systemic diseases, immunecompromised
patients.
Age minimum:
25 Years
Age maximum:
40 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Sensitivity
|
Intervention(s)
|
Other: Bulk fill composite
|
Other: Nano resin composite
|
Primary Outcome(s)
|
sensitivity
[Time Frame: one month follow up]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|